IA Day 2026 Take Two; Setting a Recovery Course Built on Incumbency

Research evidence excerpt

IA Day 2026 Take Two; Setting a Recovery Course Built on Incumbency

Computer Services & IT Consulting

DXC Technology

TD SECURITIES (USA) LLC COMPANY UPDATE

June 11, 2026

Price: $8.82 (06/11/2026) IA Day 2026 Take Two; Setting a Recovery

Price Target: $11.00 Course Built on Incumbency

HOLD (2)

ESG SCORE: 62/100

Bryan C. Bergin, CFA THE TD COWEN INSIGHT

646 562 1369

DXC's IA Day conveyed plans to modernize its solutions & leverage incumbency positioning

bryan.bergin@tdsecurities.com

as cornerstones of a recovery. Med-term targets calling for a recovery to growth, modest EBIT

Gates Schwarzmann margin improvement & FCF stability off its FY27E guidance land above Street. However, we

646 562 1363 suspect Street is unlikely to materially revise projections until there is demonstrated execution.

gates.schwarzmann@tdsecurities.com

FY27 improvement is step 1.

Key Data

Symbol NYSE: DXC Investor Day Take 1 Quick Take

Beta: 0.81 Setting a Recovery Course Built on Incumbency; Near-Term Execution Proof

52-Week Range: $16.24-$8.22 Remains Precursor to Change Sentiment

Market Cap: $1.4B

Net Debt (MM): $2,510.0 DXC's 2026 IA Day marked its first in ~5 years & first under current management, outlining

multi-year portfolio modernization and product development efforts that aim to capitalize

Cash/Share: $5.80

on DXC's incumbent position serving mission-critical IT Services at enterprise clients and the

Dil. Shares Out (MM): 178.7

Enterprise Value secular AI growth opportunity. Its med-term guidance (through FY29E) targets a recovery

$4,353.7

(MM): to growth with actions seeking to stabilize its core while generating incremental value from

BV/Share: $17.77 fast track modern solutions, modest EBIT margin improvement and FCF stability off its FY27E

Dividend: $0.00 guidance.

Yield: 0.0%